Artemis Therapeutics, Inc. Overview
Industry: Shell Companies
Sector: Financial Services
Artemis Therapeutics Inc., a beauty company, develops and distributes skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with enhanced vitamin C, day cream, night nourishing cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel. It also distributes manuka honey imported from New Zealand. The company was incorporated in 2020 and is based in Ramat Gan, Israel.
Artemis Therapeutics, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Artemis Therapeutics, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Artemis Therapeutics, Inc. Competitors
Artemis Therapeutics, Inc. operates in the Shell Companies industry within the Financial Services sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans